Cover Story
Conversation with The Cancer Letter
It’s safe to say that July 1 was a better than average day for Suresh S. Ramalingam.
In Brief
Clinical Roundup
Drugs & Targets
Trending Stories
- As Trump’s second term nears, Republican support for NIH is at a low point
By stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research - Trump 2016: A look back at the 45th president’s impact on oncology
- When cigarette filters were made of asbestos
- Cedars-Sinai spearheads first national certification program for COE staff at cancer centers
- Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- Patient navigation benefits health systems, improves care
Initial data presented at the White House come a year after CMS payment began